FDA Orange Book · active-ingredient family
Olive oil; soybean oil
Olive oil; soybean oil is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:CLINOLIPID 20% · NDA 204508
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
1
Exclusivity periods
Brand (NDA) products · emulsion
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CLINOLIPID 20%RLD | BAXTER HLTHCARE CORP | NDA 204508 | — | Oct 03, 2013 |
Marketing exclusivity (1)
- NPPNew patient population exclusivity (3 years)
Apr 24, 2027
in 10 mo
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Olive oil; soybean oil — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

